Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,857 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06102980Recruiting
Liver stiffness test during endoscopy for fatty liver disease
This study uses an ultrasound probe during a routine endoscopy to measure liver stiffness, which can help detect liver scarring (fibrosis) in people with fatty liver disease (MASLD). If you are already scheduled for an endoscopy and have no signs of advanced liver scarring, you may be able to join.
Guayaquil, GuayasAges 18–79 - NCT06101888Recruiting
New Heart Valve for Severe Aortic Leak
This study is testing a new, less invasive heart valve system (TaurusTrio) for people with severe aortic regurgitation (a leaky aortic valve) who cannot have open-heart surgery. It aims to see if the valve is safe and works well to improve symptoms.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06104033Recruiting
Drug-coated balloon for patients with heart artery disease in multiple vessels
This trial tests whether a drug-coated balloon is a good treatment option for people who have blockages in two or more heart arteries. It aims to see if this approach can safely open blocked arteries without a permanent stent.
SeoulAges 19–100 - NCT06103630Recruiting
Mouth exercises for sleep apnea with mouthguard therapy
This study tests whether specific mouth and throat exercises can help people with sleep apnea who already use a mandibular advancement device (a type of mouthguard). The goal is to see if adding exercises improves sleep and breathing.
TainanAges 20 years+ - NCT06103916Recruiting
Testing the ADNEX model for ovarian tumors
This trial is testing how well a special ultrasound model (ADNEX) can predict whether an ovarian tumor is benign or cancerous. It helps doctors make better decisions, and it’s for people with complex ovarian tumors who speak Dutch.
Veldhoven, North BrabantAges 18 years+ - NCT06104007Recruiting
Genoss balloon for narrowed heart stents
This study follows patients who have already received a special drug-coated balloon (Genoss® DCB) to treat a re-narrowed heart stent. It aims to see how safe and effective the balloon is in the long term.
SeoulAges 19 years+ - NCT06104384Recruiting
Chronic pain patients with injury claims study
This study looks at injury claims from people with chronic pain to better understand their experiences. It may help improve care for others with similar conditions.
Surrey, British ColumbiaAges 20–99 - NCT06104618RecruitingPhase 2
Enfortumab vedotin for advanced penile cancer
This trial tests a drug called enfortumab vedotin for people with advanced penile cancer (squamous cell carcinoma) that has spread or cannot be surgically removed. The goal is to see if the drug can shrink tumors or slow the cancer's growth.
Phoenix, ArizonaAges 18 years+ - NCT06104774Recruiting
Family tai chi after lung surgery for better breathing
This study tests if doing tai chi with your family can help your lungs work better and improve your mood after a thoracoscopic lung surgery. You would practice tai chi exercises and the researchers will check your breathing and mental health.
Taichung, North Dist.Ages 18 years+ - NCT06104930Recruiting
Extracellular vesicles in meningioma patients
This study is looking at tiny particles called extracellular vesicles in the blood of people with meningioma, a type of brain tumor. The goal is to learn more about these particles and how they relate to the tumor, which may help in understanding the disease better.
HeidelbergAges Any age - NCT06105554RecruitingPhase 1/Phase 2
Study of belumosudil for relapsed or refractory multiple myeloma
This trial tests a new drug called belumosudil, alone or with dexamethasone, for people with multiple myeloma that has come back or stopped responding to at least three prior treatments. The goal is to see if it can help when other therapies have stopped working.
Houston, TexasAges 18 years+ - NCT06105684RecruitingPhase 2
Low-dose capecitabine for advanced breast cancer
This trial tests a lower dose of the chemotherapy drug capecitabine in people with advanced breast cancer that is HER2 negative. It aims to see if this gentler dose works well, especially for older or frailer patients who may have more difficulty with standard treatment.
Birmingham, AlabamaAges 60 years+ - NCT06106360Recruiting
Using an Apple Watch and iPhone to monitor chemo patients at home
This study tests whether using an Apple Watch and a health app on your iPhone can help monitor how you're doing during chemotherapy. Doctors want to see if tracking your health at home can catch problems early and keep you safer.
Fairfax, VirginiaAges 18 years+ - NCT06107010Recruiting
Robotic exoskeleton for walking after stroke
This trial tests a robotic exoskeleton (Atalante) to help people who have had a stroke and have trouble walking. It looks at whether using the device early (1–4 months after stroke) can improve the ability to walk again.
CréteilAges 18 years+ - NCT06107686RecruitingPhase 2
YL202 for advanced solid tumors
This trial tests a new drug called YL202 for people with advanced solid tumors (cancers that have spread or cannot be removed). It aims to see if the drug can shrink tumors or slow cancer growth. You may be able to join if you have certain types of cancer, have not had a previous HER3 treatment, and can provide a tumor sample.
Hefei, AnhuiAges 18–75 - NCT06108674Recruiting
Phone-based pharmacist help for high blood pressure in seniors
This trial tests if a pharmacist can help older adults with uncontrolled high blood pressure manage it better through phone calls. It might be a good fit if you have a cell phone and your blood pressure is not under control.
Vitória da Conquista, Estado de BahiaAges 60 years+ - NCT06108414RecruitingPhase 4
Low-dose vs standard-dose blood thinner for older adults with atrial fibrillation
This trial tests whether a lower dose of the blood thinner rivaroxaban works as well as the standard dose for people 70 and older with atrial fibrillation (an irregular heartbeat). The goal is to find the safest dose to prevent strokes while reducing bleeding risks.
Beijing, Beijing MunicipalityAges 70 years+ - NCT06108830Recruiting
Esketamine and remimazolam for better sleep after surgery
This study tests whether a combination of two medicines (esketamine and remimazolam) can help people sleep better and feel less anxious after surgery. Researchers want to see if this approach works better than standard care.
TianjinAges 20–65 - NCT06109142Recruiting
Testing a special filter to clean blood in shock and kidney failure
This trial is testing a special blood filter (oXiris) to see if it helps remove harmful substances from the blood of people in the intensive care unit with shock and kidney failure. It may help improve blood pressure and reduce the need for strong medicines.
GarchesAges 6 years+ - NCT06109233Recruiting
MRD-guided treatment for newly diagnosed myeloma
This study is for people with newly diagnosed multiple myeloma whose cancer responded to initial treatment but still has tiny traces (minimal residual disease, or MRD). The trial will test if adjusting the next phase of therapy based on MRD levels can improve long-term outcomes.
Changchun, JilinAges 18 years+ - NCT06109493Recruiting
Psychological support for kidney dialysis patients
This trial tests a type of talk therapy (ACT) to see if it helps patients on dialysis feel better emotionally. It may be a good fit if you're on dialysis, feeling distressed, and not taking antidepressants.
MadridAges 18 years+ - NCT06111417Recruiting
Rapid BRCA1/2 test for newly diagnosed breast cancer patients
This study tests a new ultra-rapid genetic test for BRCA1/2 mutations in people recently diagnosed with breast cancer. It aims to see if the faster result helps doctors and patients make treatment decisions sooner.
DijonAges 18 years+ - NCT06112704RecruitingPhase 2
HS-20093 for advanced esophageal and other solid tumors
This trial tests an investigational drug called HS-20093 for people with advanced esophageal cancer or other solid tumors that have not responded to prior treatment. The drug targets a protein on cancer cells called B7-H3, and the study aims to see if it can shrink tumors or slow their growth.
Hefei, AnhuiAges 18 years+ - NCT06113237Recruiting
Epidiolex pregnancy safety study
This study tracks the safety of Epidiolex (a prescription CBD medicine) when taken during pregnancy. It helps doctors understand how the medicine affects pregnancy and the baby.
Morgantown, West VirginiaAges Any age
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,857 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.